U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 428

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:42083034
GRCh38:
Chr17:44005666
NAGSG153fsHyperammonemia, type IIILikely pathogenic
(Feb 17, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr17:42083391
GRCh38:
Chr17:44006023
NAGSHyperammonemia, type IIILikely pathogenic
(Oct 1, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr17:42083562
GRCh38:
Chr17:44006194
NAGSI291NHyperammonemia, type IIIConflicting interpretations of pathogenicity
(May 31, 2022)
criteria provided, conflicting interpretations
4.
GRCh37:
Chr17:42083045
GRCh38:
Chr17:44005677
NAGSS156NHyperammonemia, type IIIUncertain significance
(Sep 17, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr17:42083491
GRCh38:
Chr17:44006123
NAGSHyperammonemia, type IIILikely benign
(Mar 29, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr17:42082114
GRCh38:
Chr17:44004746
NAGSA28VHyperammonemia, type IIIUncertain significance
(Sep 2, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr17:42085059
GRCh38:
Chr17:44007691
NAGSG457SHyperammonemia, type IIIUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr17:42082267
GRCh38:
Chr17:44004899
NAGSS79LHyperammonemia, type III, Inborn genetic diseasesConflicting interpretations of pathogenicity
(Dec 14, 2021)
criteria provided, conflicting interpretations
9.
GRCh37:
Chr17:42084793
GRCh38:
Chr17:44007425
NAGSG400AHyperammonemia, type IIIUncertain significance
(May 21, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr17:42079006
GRCh38:
Chr17:44001638
NAGS, PYYHyperammonemia, type IIIUncertain significance
(Mar 30, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr17:42085058
GRCh38:
Chr17:44007690
NAGSHyperammonemia, type IIILikely benign
(Sep 19, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr17:42084954
GRCh38:
Chr17:44007586
NAGSHyperammonemia, type IIILikely benign
(Oct 3, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr17:42083917
GRCh38:
Chr17:44006549
NAGSHyperammonemia, type IIILikely benign
(Aug 7, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr17:42083106
GRCh38:
Chr17:44005738
NAGSHyperammonemia, type IIILikely benign
(Dec 24, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr17:42082169
GRCh38:
Chr17:44004801
NAGSHyperammonemia, type IIILikely benign
(Mar 18, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr17:42082033
GRCh38:
Chr17:44004665
NAGSM1THyperammonemia, type IIIUncertain significance
(Oct 17, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr17:42082103
GRCh38:
Chr17:44004735
NAGSHyperammonemia, type IIILikely benign
(Oct 5, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr17:42083119
GRCh38:
Chr17:44005751
NAGST181AHyperammonemia, type IIIUncertain significance
(Jul 15, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr17:42083189
GRCh38:
Chr17:44005821
NAGSV204AHyperammonemia, type IIIUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
20.
GRCh37:
Chr17:42083566
GRCh38:
Chr17:44006198
NAGSF292LHyperammonemia, type IIIUncertain significance
(Jul 24, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr17:42083400
GRCh38:
Chr17:44006032
NAGSG237DHyperammonemia, type IIIUncertain significance
(Mar 18, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr17:42083486
GRCh38:
Chr17:44006118
NAGSA266SHyperammonemia, type IIIUncertain significance
(Jun 28, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr17:42083299
GRCh38:
Chr17:44005931
NAGSHyperammonemia, type IIILikely benign
(Aug 22, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr17:42082120
GRCh38:
Chr17:44004752
NAGSR30KHyperammonemia, type IIIUncertain significance
(Aug 23, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr17:42082156
GRCh38:
Chr17:44004788
NAGSG42VHyperammonemia, type IIIUncertain significance
(Jan 19, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr17:42085888
GRCh38:
Chr17:44008520
NAGSI508MHyperammonemia, type IIIUncertain significance
(Mar 23, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr17:42083114
GRCh38:
Chr17:44005746
NAGSA179VHyperammonemia, type IIIUncertain significance
(Apr 24, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr17:42083571
GRCh38:
Chr17:44006203
NAGSN294SHyperammonemia, type IIIUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr17:42082096
GRCh38:
Chr17:44004728
NAGSR22PHyperammonemia, type IIIUncertain significance
(Mar 5, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr17:42084037
GRCh38:
Chr17:44006669
NAGSHyperammonemia, type IIILikely benign
(Jul 22, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr17:42082472
GRCh38:
Chr17:44005104
NAGSHyperammonemia, type IIILikely benign
(Oct 17, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr17:42085916
GRCh38:
Chr17:44008548
NAGSA518THyperammonemia, type IIIConflicting interpretations of pathogenicity
(Jul 29, 2022)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr17:42085014
GRCh38:
Chr17:44007646
NAGSL442VHyperammonemia, type IIIUncertain significance
(Oct 19, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr17:42084822
GRCh38:
Chr17:44007454
NAGSS410PHyperammonemia, type IIIUncertain significance
(Mar 29, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr17:42084824
GRCh38:
Chr17:44007456
NAGSHyperammonemia, type IIILikely benign
(May 20, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr17:42084876
GRCh38:
Chr17:44007508
NAGSHyperammonemia, type IIIBenign
(May 9, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr17:42083475
GRCh38:
Chr17:44006107
NAGSG262AHyperammonemia, type IIIUncertain significance
(May 12, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr17:42082145-42082146
GRCh38:
Chr17:44004777-44004778
NAGSR41fsHyperammonemia, type IIIPathogenic
(Apr 29, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr17:42083899
GRCh38:
Chr17:44006531
NAGSHyperammonemia, type IIILikely benign
(Apr 17, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr17:42082163
GRCh38:
Chr17:44004795
NAGSP45fsHyperammonemia, type IIIPathogenic
(Mar 31, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr17:42082292
GRCh38:
Chr17:44004924
NAGSHyperammonemia, type IIILikely benign
(Mar 27, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr17:42083468
GRCh38:
Chr17:44006100
NAGSP260THyperammonemia, type IIIUncertain significance
(Jun 13, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr17:42083965
GRCh38:
Chr17:44006597
NAGSK328NHyperammonemia, type IIIUncertain significance
(Mar 23, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr17:42083286
GRCh38:
Chr17:44005918
NAGSHyperammonemia, type IIILikely benign
(Mar 18, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr17:42082102
GRCh38:
Chr17:44004734
NAGSG24DHyperammonemia, type IIIUncertain significance
(Mar 16, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr17:42083091
GRCh38:
Chr17:44005723
NAGSHyperammonemia, type IIILikely benign
(May 29, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr17:42082151
GRCh38:
Chr17:44004783
NAGSHyperammonemia, type IIILikely benign
(Sep 30, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr17:42082229
GRCh38:
Chr17:44004861
NAGSHyperammonemia, type IIILikely benign
(Mar 18, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr17:42082373
GRCh38:
Chr17:44005005
NAGSHyperammonemia, type IIILikely benign
(Mar 9, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr17:42082178
GRCh38:
Chr17:44004810
NAGSHyperammonemia, type IIILikely benign
(Apr 18, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr17:42083180
GRCh38:
Chr17:44005812
NAGSK201THyperammonemia, type IIIUncertain significance
(Mar 4, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr17:42084704
GRCh38:
Chr17:44007336
NAGSHyperammonemia, type IIILikely benign
(Feb 18, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr17:42084869
GRCh38:
Chr17:44007501
NAGSHyperammonemia, type IIILikely benign
(Oct 14, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr17:42084016
GRCh38:
Chr17:44006648
NAGSHyperammonemia, type IIILikely benign
(Feb 10, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr17:42083385
GRCh38:
Chr17:44006017
NAGSHyperammonemia, type IIILikely benign
(Feb 9, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr17:42084010
GRCh38:
Chr17:44006642
NAGSHyperammonemia, type IIILikely benign
(Feb 2, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr17:42084043
GRCh38:
Chr17:44006675
NAGSHyperammonemia, type IIILikely benign
(Apr 11, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr17:42082361
GRCh38:
Chr17:44004993
NAGSHyperammonemia, type IIILikely benign
(Sep 3, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr17:42084945
GRCh38:
Chr17:44007577
NAGSHyperammonemia, type IIILikely benign
(Oct 13, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr17:42082384
GRCh38:
Chr17:44005016
NAGSG118AHyperammonemia, type IIIUncertain significance
(Mar 5, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr17:42083471
GRCh38:
Chr17:44006103
NAGSI261VHyperammonemia, type IIIUncertain significance
(Sep 1, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr17:42082146
GRCh38:
Chr17:44004778
NAGSA39THyperammonemia, type IIIUncertain significance
(Aug 8, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr17:42084857
GRCh38:
Chr17:44007489
NAGSHyperammonemia, type IIILikely benign
(Jun 14, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr17:42082265
GRCh38:
Chr17:44004897
NAGSHyperammonemia, type IIILikely benign
(Aug 21, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr17:42082224
GRCh38:
Chr17:44004856
NAGSG65SHyperammonemia, type IIIUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr17:42083930
GRCh38:
Chr17:44006562
NAGSD317NHyperammonemia, type IIIUncertain significance
(Jan 2, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr17:42084786
GRCh38:
Chr17:44007418
NAGSS398CHyperammonemia, type IIIUncertain significance
(Aug 12, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr17:42082364
GRCh38:
Chr17:44004996
NAGSHyperammonemia, type IIILikely benign
(Jan 5, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr17:42083614-42083617
GRCh38:
Chr17:44006246-44006249
NAGSHyperammonemia, type IIILikely benign
(Nov 1, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr17:42082417
GRCh38:
Chr17:44005049
NAGST129SHyperammonemia, type IIIUncertain significance
(Jul 15, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr17:42082212
GRCh38:
Chr17:44004844
NAGSE61QHyperammonemia, type IIIUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr17:42083467
GRCh38:
Chr17:44006099
NAGSHyperammonemia, type IIILikely benign
(Oct 20, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr17:42082236
GRCh38:
Chr17:44004868
NAGSV69LHyperammonemia, type IIIUncertain significance
(Dec 7, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr17:42083388
GRCh38:
Chr17:44006020
NAGSHyperammonemia, type IIILikely benign
(Oct 2, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr17:42084980
GRCh38:
Chr17:44007612
NAGSHyperammonemia, type IIILikely benign
(Sep 23, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr17:42082289
GRCh38:
Chr17:44004921
NAGSHyperammonemia, type IIILikely benign
(Sep 21, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr17:42083530
GRCh38:
Chr17:44006162
NAGSHyperammonemia, type IIILikely benign
(Sep 18, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr17:42085124
GRCh38:
Chr17:44007756
NAGSHyperammonemia, type IIILikely benign
(Sep 14, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr17:42084968
GRCh38:
Chr17:44007600
NAGSHyperammonemia, type IIILikely benign
(Aug 30, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr17:42083097
GRCh38:
Chr17:44005729
NAGSHyperammonemia, type IIILikely benign
(Aug 17, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr17:42083458
GRCh38:
Chr17:44006090
NAGSHyperammonemia, type IIILikely benign
(Aug 5, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr17:42084809
GRCh38:
Chr17:44007441
NAGSHyperammonemia, type IIILikely benign
(Aug 5, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr17:42084025
GRCh38:
Chr17:44006657
NAGSHyperammonemia, type IIILikely benign
(Jul 8, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr17:42084971
GRCh38:
Chr17:44007603
NAGSHyperammonemia, type IIILikely benign
(Jul 6, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr17:42085079
GRCh38:
Chr17:44007711
NAGSC463WHyperammonemia, type IIIUncertain significance
(Jul 4, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr17:42083920
GRCh38:
Chr17:44006552
NAGSHyperammonemia, type IIILikely benign
(Jun 28, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr17:42082320
GRCh38:
Chr17:44004952
NAGSS97PHyperammonemia, type IIIUncertain significance
(May 25, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr17:42082265
GRCh38:
Chr17:44004897
NAGSHyperammonemia, type IIILikely benign
(May 22, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr17:42083376
GRCh38:
Chr17:44006008
NAGSHyperammonemia, type IIILikely benign
(Oct 5, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr17:42083169
GRCh38:
Chr17:44005801
NAGSHyperammonemia, type IIILikely benign
(Oct 11, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr17:42083130
GRCh38:
Chr17:44005762
NAGSHyperammonemia, type IIILikely benign
(Aug 10, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr17:42084094-42084124
GRCh38:
Chr17:44006726-44006756
NAGSHyperammonemia, type IIILikely benign
(Sep 28, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr17:42083094
GRCh38:
Chr17:44005726
NAGSHyperammonemia, type IIILikely benign
(May 7, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr17:42084094
GRCh38:
Chr17:44006726
NAGSHyperammonemia, type IIILikely benign
(Mar 11, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr17:42082145
GRCh38:
Chr17:44004777
NAGSHyperammonemia, type IIILikely benign
(Oct 19, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr17:42083259
GRCh38:
Chr17:44005891
NAGSHyperammonemia, type IIILikely benign
(Mar 20, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr17:42084761
GRCh38:
Chr17:44007393
NAGSHyperammonemia, type IIILikely benign
(Mar 27, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr17:42083130
GRCh38:
Chr17:44005762
NAGSHyperammonemia, type IIILikely benign
(Aug 23, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr17:42083122
GRCh38:
Chr17:44005754
NAGSA182PHyperammonemia, type IIIUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr17:42083437
GRCh38:
Chr17:44006069
NAGSHyperammonemia, type IIILikely benign
(Mar 10, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination